These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26851874)

  • 21. Adverse cutaneous drug reactions in a single quaternary referral hospital.
    Botelho LF; Porro AM; Enokihara MM; Tomimori J
    Int J Dermatol; 2016 Apr; 55(4):e198-203. PubMed ID: 26710962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should benznidazole be used in chronic Chagas' disease?
    Bestetti RB
    Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thioctic acid in the prevention of the toxic effects of benznidazole].
    Pérez Lloret A; Roldán EJ
    Medicina (B Aires); 1984; 44(1):108. PubMed ID: 6443012
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug reaction with eosinophilia and systemic symptoms syndrome induced by benznidazole.
    Moreno-Escobosa C; Cruz-Granados S
    Contact Dermatitis; 2018 Aug; 79(2):105-106. PubMed ID: 29635801
    [No Abstract]   [Full Text] [Related]  

  • 25. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.
    Lehloenya RJ; Todd G; Wallace J; Ngwanya MR; Muloiwa R; Dheda K
    Br J Dermatol; 2016 Jul; 175(1):150-6. PubMed ID: 26918554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of Chagas disease with benznidazole and thioctic acid].
    Roldán EJ
    Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
    [No Abstract]   [Full Text] [Related]  

  • 28. Serious and life-threatening drug eruptions.
    Manders SM
    Am Fam Physician; 1995 Jun; 51(8):1865-72. PubMed ID: 7762478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease.
    Pinazo MJ; Guerrero L; Posada E; Rodríguez E; Soy D; Gascon J
    Antimicrob Agents Chemother; 2013 Jan; 57(1):390-5. PubMed ID: 23114763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
    Moya PR; Trombotto GT
    Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.
    Franco LAM; Moreira CHV; Buss LF; Oliveira LC; Martins RCR; Manuli ER; Lindoso JAL; Busch MP; Pereira AC; Sabino EC
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical overview: adverse cutaneous reactions to psychotropic medications.
    Kimyai-Asadi A; Harris JC; Nousari HC
    J Clin Psychiatry; 1999 Oct; 60(10):714-25; quiz 726. PubMed ID: 10549695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug eruptions from phenylbutazone in Jamu.
    Giam YC; Tham SN; Tan T; Lim A
    Ann Acad Med Singap; 1986 Jan; 15(1):118-21. PubMed ID: 2939787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benznidazole for the treatment of Chagas disease.
    Losada Galván I; Alonso-Padilla J; Cortés-Serra N; Alonso-Vega C; Gascón J; Pinazo MJ
    Expert Rev Anti Infect Ther; 2021 May; 19(5):547-556. PubMed ID: 33043726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to Antinori et al.
    Miller DA; Traina MM; Meymandi SK
    Clin Infect Dis; 2015 Jun; 60(12):1875-6. PubMed ID: 25805304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.